InvestorsHub Logo
Followers 116
Posts 1878
Boards Moderated 0
Alias Born 11/22/2017

Re: john1045 post# 204858

Monday, 12/24/2018 8:24:34 AM

Monday, December 24, 2018 8:24:34 AM

Post# of 704497
john1045,

good find! Thanks!! I like the title!!!

IN THE NEWS
Campbell Lecturer Details New Directions in Brain Cancer Treatment
December 20, 2018 | Goodman Campbell | Brain Health, Events

Liau also described one of the main challenges is measuring whether an immunotherapy drug is working against a glioblastoma tumor. After injections of these drugs, a tumor may enlarge (“pseudoprogression”) for possibly 6 months before it gets smaller.
Therefore, standard imaging techniques, such as MRI, to assess whether tumors are growing or shrinking in response to treatment are not as sufficient in brain cancer.
https://www.goodmancampbell.com/in-the-news/campbell-lecturer-details-new-directions-in-brain-cancer-treatment



Here is an example of that "wait and see".

July 30, 2015 at 1:17 pm
Report
My dad is in the DC Vax L trial and just started the cross over arm about 2 weeks ago. He's received 2 injections so far and 1 next week since he's been in the cross over arm.

He started the trial around a year ago and was crossed over 2 weeks ago due to progression. At first Drs thought it was scar tissue but after 3 mris (6 month time frame), it became more clear it was slow tumor growth.


Source: Inspire.com

Merry Christmas!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News